37 employees
Lumos Pharma is a biopharmaceutical company that develops a novel treatment for the rare disease Creatine Transporter Deficiency.
1999
$34M
from 3 investors over 3 rounds
Lumos Pharma raised $34M on April 6, 2016
Investors: Clarus Ventures, LLC and -
Lumos Pharma raised $14M on February 4, 2014
Investors: -